Schedule 13G
PRAX Schedule 13G filing by Capital Research Global Investors
Capital Research Global Investors reported beneficial ownership of 997.1K shares, representing 5.6% of Praxis Precision Medicines, Inc. in this filing.
FiledNov 12, 2024
Ownership dateSep 30, 2024
Reported shares997.1K
Reported ownership5.6%
Ownership details
Voting and dispositive power reported in the filing
These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.
Sole voting power
997.1K
Shared voting power
997.1K
Sole dispositive power
997.1K
Shared dispositive power
997.1K
Price context
Price dates alongside the ownership filing
Price data provides market context around the disclosure. It does not identify the filer’s actual transaction price.
Close near filing date$82.97as of Nov 12, 2024
Latest tracked price$319.23as of Aug 5, 2026
Source
Original filing and accession
Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.
- Reporting filer
- Capital Research Global Investors
- CIK
- CIK0001422848
- Accession
- 0001422848-24-000366
- Form
- Schedule 13G
Read the filing in context